Use and Characteristics of Clinical Coding for Post-COVID Conditions in a Retrospective US Cohort
September 2025Journal of Public Health Management & Practice
Health Care Cost Savings and Utilization Reductions Associated With Virtual Physical Therapy Care: A Propensity-Matched Claims Analysis
August 2025Physical Therapy
Advanced Liver Disease Events in People with HIV and Hepatitis B Virus Coinfection Initiating Antiretroviral Therapy in the United States
July 2025Infectious Diseases and TherapyInfectious Diseases
Receipt of Buprenorphine and Naltrexone for Opioid Use Disorder by Race and Ethnicity and Insurance Type
June 2025JAMA Netw OpenInfectious Diseases
Lipid-Lowering Therapy Patterns of High-Risk Cardiovascular Patients without Prior Myocardial Infarction or Stroke—VESALIUS-REAL—Results from Patients with High-Risk Diabetes in the U.S.
June 2025DiabetesInfectious Diseases
Subsequent treatments and outcomes in bacillus Calmette-Guerin–unresponsive patients with high-risk non-muscle invasive bladder cancer with carcinoma in situ: A real-world data analysis
May 2025Journal of Clinical OncologyOncology
2023-2024 COVID-19 vaccine uptake among immunocompromised individuals in two US states
May 2025VaccineCOVID-19
Enhancing clinical trial screening with a comprehensive large language model platform
May 2025ASCOHEOR
Evolution of the Treatment Landscape for Patients Diagnosed with Amyotrophic Lateral Sclerosis in the United States
April 2025NeurologyNeurology
Real-world Human Immunodeficiency Virus RNA and Antigen/Antibody Testing Among People Who Use Long-acting Injectable Preexposure Prophylaxis
April 2025Clinical Infectious DiseasesInfectious Disease
Clinical burden, treatment, and disease control in patients with chronic spontaneous urticaria: Real-world evidence
March 2025AAA&IHEOR
National Demographic Trends and Approval Rates for Omalizumab Use to Treat Food Allergy: A Retrospective Claims-Based Analysis Since FDA Approval
February 2025Journal of Allergy and Clinical ImmunologyImmunology
Development of Novel Progression Score to Quantify Disease Progression in Crohn’s Disease
February 2025Inflammatory Bowel DiseasesHEOR
Evaluating the Effectiveness of mRNA-1273.815 Against COVID-19 Hospitalization Among Adults Aged ≥ 18 Years in the United States
December 2024Infectious Diseases and TherapyCOVID-19
Real-world healthcare resource utilization of Alzheimer’s disease in the early and advanced stages: a retrospective cohort study
December 2024JMENEUROLOGY
Appropriateness of Immunoglobulin M Testing for Measles, Mumps, and Rubella
December 2024AJPMInfectious Disease
A Retrospective Database Analysis of Healthcare Resource Utilization in Patients with Warm Autoimmune Hemolytic Anemia in the United States
November 2024BLOODHEMATOLOGY
Real-World Characteristics and Treatment History of Patients with Paroxysmal Nocturnal Hemoglobinuria Initiating Iptacopan in US Administrative Claims Data
November 2024BloodHEMATOLOGY
Inovalon Closed Payer Claims from HealthVerity Marketplace Rates of Obliteran Bronchiolitis with Lung Biopsy Among Soldiers with Military Deployment
October 2024Chest JournalRARE DISEASE
MDS-536 Clinical Characteristics and Outcomes in Complement-Inhibitor–Treated Patients With Paroxysmal Nocturnal Hemoglobinuria in the United States: A Retrospective Claims Database Analysis
September 2024CLMLRARE DISEASE
Sexually Transmitted Infection/Human Immunodeficiency Virus (STI/HIV) Testing, STIs, and HIV Pre-exposure Prophylaxis Use Among Men Who Have Sex With Men and Men Who Have Sex With Men and Women in the United States, 2019–2022
June 2024Clinical Infectious DiseasesINFECTIOUS DISEASE
Treatment patterns with intravesical bacillus Calmette-Guérin (BCG) in patients with non-muscle-invasive bladder cancer (NMIBC): A real-world data analysis
May 2024Journal of Clinical OncologyONCOLOGY
#2066 Treatment patterns of patients with complement 3 glomerulopathy (C3G): a retrospective linked electronic medical record (EMR) and claims analysis
May 2024Nephrology Dialysis TransplantationRARE DISEASE
Incidence of Herpes Zoster and Postherpetic Neuralgia and Herpes Zoster Vaccination Uptake in a US Administrative Claims Database
May 2024OPEN FORUM INFECTIOUS DISEASEINFECTIOUS DISEASE
Cenobamate Use as Monotherapy: A Retrospective Claims-based Analysis (P8-1.013)
April 2024NeurologyNEUROLOGY
A Retrospective Cohort Study of Recent Large Multiple Commercial Payer Databases to Elucidate Migraine-Specific Costs of Care by Specific Treatment Groups
April 9 2024NeurologyNeurology
Effectiveness of Cenobamate in Pediatric Patients with Intractable Focal Seizures: A Retrospective Claims-Based Analysis
May 20 2024NeurologyNeurology
Economic burden of patients with post-surgical chronic and transient hypoparathyroidism in the United States examined using insurance claims data
April 18 2024Orphanet Journal of Rare DiseasesRare Disease
Remdesivir is Associated with Reduced Mortality in Patients Hospitalized for COVID-19 Not Requiring Supplemental Oxygen
April 16 2024open forum infectious diseasesCOVID-19
A Retrospective Cohort Study of Recent Large Multiple Commercial Payer Databases to Elucidate Migraine-specific Health Care Resource Utilization (HCRU), and Migraine-specific Costs of Care
April 9 2024NeurologyNeurology
Effectiveness of Cenobamate in Pediatric Patients with Lennox-Gastaut Syndrome: A Retrospective Claims-Based Analysis
April 9 2024NeurologyNeurology
Effectiveness of Cenobamate in Postsurgical Patients: A Retrospective Claims-based Analysis
April 9 2024NeurologyNeurology
Detailed Analysis of Current Migraine Treatment Trends by Treatment Groups in a Large Retrospective Cohort Study of Recent Large Multiple Commercial Payer Databases
April 9 2024NeurologyNeurology
Effectiveness of Cenobamate in Reducing Focal Onset Seizure-related Hospitalizations: A Retrospective Claims-based Analysis
April 9 2024NeurologyNeurology
Comprehensive Analysis of Migraine Burden and Treatment Trends: A Retrospective Cohort Study of Recent Large Multiple Commercial Payer Databases
April 9 2024NeurologyNeurology
Real-World Effectiveness of a Third Dose of mRNA-1273 versus BNT162b2 on Inpatient and Medically Attended COVID-19 among Immunocompromised Adults in the United States
January 31 2024medRxivCOVID-19
MRD Assessment in Patients with Newly Diagnosed Multiple Myeloma Using Tokenized Real World Data Sources
November 29 2023BloodOncology
Prevalence and Treatment of Genital Herpes in a United States Administrative Claims Database
November 27 2023Open Forum Infectious DiseasesViral Infections
Cytomegalovirus Testing Rates Among Immunocompromised Adults, Adolescents, And Children In The United States
November 27 2023Open Forum Infectious DiseasesViral Infections
Incidence of Herpes Zoster and Postherpetic Neuralgia and Herpes Zoster Vaccination in a United States Administrative Claims Database
November 27 2023Open Forum Infectious DiseasesViral Infections
Healthcare Resource Utilization and Costs among Patients with COVID-19 in the United States
November 27 2023Open Forum Infectious DiseasesCOVID-19
Demographics, Characteristics and Health Outcomes of US Individuals Diagnosed With COVID-19 in the Outpatient Setting
November 27 2023Open Forum Infectious DiseasesCOVID-19
Use of Paxlovid for Treatment of Acute COVID-19 and Occurrence of Post-COVID Conditions among Children and Adults at High-Risk for Severe COVID-19, April 1 – December 31, 2022
November 27 2023Open Forum Infectious DiseasesCOVID-19
Contemporary Patterns and Predictors of Influenza and COVID-19 Vaccination Among US Adults During the COVID-19 Pandemic
November 27 2023Open Forum Infectious DiseasesCOVID-19 / Influenza
Testing for Cytomegalovirus Among Individuals Who Were Immunocompromised, 2018-2022
November 27 2023jama networkViral Infections
Use of Tokens to Unlock Greater Data Sharing in Health Care
November 20 2023JAMATechnology
Incidence Rates for an Extensive List of Adverse Events of Special Interest in the Pre-COVID-19 and Active COVID-19 Eras: A Comprehensive Source for Representative Historical Background Rates in the US General Population
November 2023Value in HealthCOVID-19
Characterization of Long-COVID Phenotypes and Associated Clinical Phenotypes in Administrative Claims Data
November 2023Value in HealthCOVID-19
Real-World Comparative COVID-19 Vaccine Effectiveness of a Third Dose of mRNA-1273 Versus BNT162b2 Among Immunocompromised Adults in the US
November 2023Value in HealthCOVID-19
Remdesivir reduces progression to ICU in patients hospitalized with COVID-19
October 27 2023European Respiratory JournalCOVID-19
Dementia risk in patients with heart disease and depression
October 23, 2023Dement NeuropsycholNeurology
Landscape review of global real-world data sources for studying medication use in pregnancy and lactation that support regulatory decision making
October 18 2023PDSOther
Signal detection, refinement, & evaluation of cerebral venous sinus thrombosis following Spikevax administration in a US active surveillance… (Abstract #1252)
October 12 2023ICPE 2023 #1252COVID-19
Methodological development of an enhanced safety surveillance for the Janssen COVID-19 vaccine (JCOVDEN) through rapid cycle analysis of US administrative claims data (Abstract #1291)
October 12 2023ICPE 2023 #1291COVID-19
Utilization of a hybrid data environment linking registry, claims and EHR to identify myocarditis patients (Abstract #1261)
October 12 2023ICPE 2023 #1261COVID-19
Active surveillance and evaluation of anosmia/ageusia following mRNA-1273 administration: Learnings from a US administrative claims database study (Abstract #1076)
October 12 2023ICPE 2023 #1076COVID-19
Appropriate washout period for adverse events of special interest (AESI) in vaccine active surveillance utilizing an administrative claims database (Abstract #790)
October 12 2023ICPE 2023 #790COVID-19
Background rates of pediatric-onset type I diabetes before and during the COVID-19 pandemic (Abstract #475)
October 12 2023ICPE 2023 #475COVID-19
Clinical characteristics and healthcare resource utilization among patients identified with post-acute sequelae of COVID-19 (long-COVID) in US administrative claims data (Abstract #426)
October 12 2023ICPE 2023 #426COVID-19
Background rates of cardiovascular events in patients at high risk of severe COVID-19 before and during the COVID-19 pandemic (Abstract #388)
October 12 2023ICPE 2023 #388COVID-19
Myocarditis risk following immunization with Spikevax primary series and booster doses in a US administrative database (Abstract #80)
October 12 2023ICPE 2023 #80COVID-19
Active vaccine safety surveillance utilizing administrative data: evaluating the use of open + closed claims versus closed claims alone (Abstract #79)
October 12 2023ICPE 2023 #79COVID-19
Concordance between analyses from the moderna global safety database (GSD) and a US population-based study for COVID-19 vaccine, mRNA-1273 (Abstract #78)
October 12 2023ICPE 2023 #78COVID-19
Characteristics and outcomes of pregnancies in the Maternal Outcomes Masterset real-world database
September 25, 2023PDSOther
Real-world analysis of retention on cenobamate in patients with epilepsy in the United States
September 21, 2023Epilepsy ResearchNeurology
Hospitalization Among Patients Treated With Molnupiravir: A Retrospective Study of Administrative Data
August 17, 2023Clinical TherapeuticsCovid-19
Health Care Resource Utilization and Costs for Patients with Spinal Muscular Atrophy: Findings from a Retrospective US Claims Database Analysis
August 16, 2023Advances in TherapyRare Disease
The burden of untreated insomnia disorder in a sample of 1 million adults: a cohort study
August 3, 2023BMC Public HealthNeurology
Continuity of care among patients newly initiated on second-generation oral or long-acting injectable antipsychotics during a schizophrenia-related inpatient stay
July 28, 2023CMRONeurology
SARS-CoV-2 spike-protein targeted serology test results and their association with subsequent COVID-19-related outcomes
July 25, 2023FrontiersCovid-19
A Descriptive Cohort Study of Drug Utilization Patterns Among Patients Hospitalized With Coronavirus Disease 2019 in the United States, January 2021–February 2022
July 10, 2023Oxford AcademicCovid-19
Estimating real-world treatment effects under a rapidly evolving treatment paradigm
June 2, 2023FDA Science ForumCOVID-19
Trial Tokenization Accelerating Innovation in SEPRA – A Pragmatic Randomized Trial
June 2023Value in HealthDiabetes
Association between the real-world use of trazodone and daytime impairment in US patients with insomnia
May 29, 2023SleepNeurology
Association between the real-world use of GABA receptor agonists and daytime impairment in US patients with insomnia
May 29, 2023SleepNeurology
Real-World Modifications of Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Hyperkalemia Initiating Sodium Zirconium Cyclosilicate Therapy: The OPTIMIZE I Study
May 4, 2023Advances in TherapyGenitourinary
Rates of Inpatient Hospitalizations Across a 2-Year Time Horizon Between reSET-O and Control Patients: A Difference in Differences Approach
April 14 2023cns spectrumsDigital Therapeutics
Risk of and duration of protection from SARS-CoV-2 reinfection assessed with real-world data
March 21, 2023PLOSCovid-19
Assessing Vulnerability to COVID-19 in High-Risk Populations: The Role of SARS-CoV-2 Spike-Targeted Serology
February 14, 2023LiebertCovid-19
Real-world utilization of SARS-CoV-2 serological testing in RNA positive patients across the United States
February 10, 2023PLOSCovid-19
Real-world performance of SARS-Cov-2 serology tests in the United States, 2020
February 3, 2023PLOSCovid-19
Impact on hospitalizations of long-term versus short-term therapy with sodium zirconium cyclosilicate during routine outpatient care of patients with hyperkalemia: the recognize I study
December 28, 2022Expert ReviewGenitourinary
Association of Remdesivir Treatment With Mortality Among Hospitalized Adults With COVID-19 in the United States
December 1, 2022JAMA NetworkCovid-19
Long acting reversible contraceptive (larc) insertions in 2019 in the states with most restrictive and trigger abortion policies
November 18, 2022ContraceptionReproductive Health
Evaluation of VTE, MACE, and Serious Infections Among Patients with RA Treated with Baricitinib Compared to TNFi: A Multi-Database Study of Patients in Routine Care Using Disease Registries and Claims Databases
November 13, 2022Rheumatology and TherapyImmunology
Use of the Postacute Sequelae of COVID-19 Diagnosis Code in Routine Clinical Practice in the US
October 6, 2022JAMA NetworkCovid-19
Real-world comparative effectiveness of mRNA-1273 and BNT162b2 vaccines among immunocompromised adults identified in administrative claims data in the United States
September 23, 2022NIHCovid-19
The impact of data truncation on rates of vaccine-associated adverse events utilizing open and closed claims: Lessons from post-marketing safety surveillance of the SARS-COV-2 MRNA-1273 vaccine (Abstract #186)
September 23 2022ICPE 2022 #186COVID-19
Durability of Protection Post-Primary COVID-19 Vaccination in the United States
September 3 2022vaccinesCOVID-19
Real-world Utilization of SARS-CoV-2 Serological Testing in RNA Positive Patients Across the United States
September 1, 2022FDACovid-19
Data lag in a large open and closed claims dataset: Navigating the completeness-timeliness tradeoff
September 1, 2022AetionOther
Coronavirus Disease 2019 Severity and Risk of Subsequent Cardiovascular Events
August 19, 2022Oxford AcademicCovid-19
Vital Signs: Hepatitis C Treatment Among Insured Adults
August 9, 2022CDCViral Infections
Post–COVID-19 Symptoms and Conditions Among Children and Adolescents
August 5, 2022CDCCOVID-19
Assessing the Relationship between Heart Disease and Related Comorbidities with Dementia and Alzheimer’s Disease
July 2022Value in HealthNeurology
Investigation into the Geriatric Population with Poorly Controlled Diabetes and the Effects on Hospitalizations
July 2022Value in HealthMetabolic
Categorization of COVID-19 severity to determine mortality risk
April 4, 2022NIHCOVID-19
Durability of the Single-Dose Ad26.COV2.S Vaccine in the Prevention of COVID-19 Infections and Hospitalizations in the US Before and During the Delta Variant Surge
March 17, 2022JAMA NetworkCOVID-19
Unraveling COVID-19: A Large-Scale Characterization of 4.5 Million COVID-19 Cases Using CHARYBDIS
